Latest Breaking News On - Aprea therapeutics inc - Page 7 : comparemela.com

Aprea Therapeutics to Host a Key Opinion Leader (KOL) Event on its Synthetic Lethality (SL) and DNA Damage Response (DDR) Pathways - Aprea Therapeutics (NASDAQ:APRE)

DOYLESTOWN, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea", or the "Company"), a clinical stage biopharmaceutical company focused on precision oncology through synthetic

City ofUnited kingdomUnited statesUniversity of pennsylvaniaFiona simpkinsTimothy yapTimothya yapMike moyerNational institute for health researchJohns hopkins universityExchange commissionDepartment of thoracic headHead of clinical developmentInstitute for personalized cancer therapyTherapeutics discovery divisionCancer research training

Critical Survey: Aprea Therapeutics (NASDAQ:APRE) and Morphic (NASDAQ:MORF)

Critical Survey: Aprea Therapeutics (NASDAQ:APRE) and Morphic (NASDAQ:MORF)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesChildren medical center corporationMorphic holding incAprea therapeutics incAprea therapeuticsGet free reportGiven aprea therapeuticNext genMedical center corporationAprea therapeutics daily

Form PRER14A Timber Pharmaceuticals,

Form PRER14A Timber Pharmaceuticals,
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkState of delawareNew jerseyNew castle countyGianluca pirozziLowenstein sandlerJesper brandgaardCovington burlingSteven skolnickPhilip eickhoffJoseph luccheseCasey lindstromDavid cohenAlan mendelsohnCoherus biosciences

Aprea Therapeutics (APRE) Appoints Dr Jean-Pierre Bizzari to its Board

Aprea Therapeutics (APRE) Appoints Dr Jean-Pierre Bizzari to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalOxford biotherapeuticsRichard petersChris schadeRhone poulenc rorerOren giladJean pierre bizzariChristian schadeEuropean organization of researchGroup head clinical development oncology at celgeneDrug advisory committeeCompensation committeeAprea therapeutics incAprea therapeuticsGroup head clinical development oncologyChief executive officer

2023-08-24 | NDAQ:APRE | Press Release | Aprea Therapeutics Inc

(2023-08-24 | NDAQ:APRE) Aprea Therapeutics Appoints Dr. Jean-Pierre Bizzari to its Board of Directors and Names Dr. Richard Peters as Chairman

United statesFrance generalMike moyerJean pierre bizzariOren giladChristian schadeRhone poulenc rorerChris schadeRichard petersOxford biotherapeuticsAprea closecurlydoublequoteExchange commissionGroup head clinical development oncology at celgeneCompany closecurlyquoteCompensation committeeAprea therapeutics inc